Cardiovascular diseases/Cerebrovascular diseases/lifestyle-related diseases
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patients with cardiovascular diseases, cerebrovascular diseases and lifestyle-related diseases, and their relatives who are willing to accept the analyses of lipid profile and gene 2)Patients who gave written informed consent
Exclusion criteria
Exclusion criteria: 1)Subjects with known bleeding tendency 2)Subjects with anemia 3)Subjects whose doctor in charge do not agree to join the trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lipid profile including cholesterol efflux etc.Gene analysis(SNPs,deletion, insertion,CNV,expression etc) | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood and urine analyses including Hemoglobin A1c levels, Urinary acid, Markers indicating obesity (e.g. adiponectin), inflammation (high sensitive CRP), oxidative stress (8-OHdG/ MDA-LDL), early-staged kidney diseases (microalbuminuria) | — |
Countries
Japan
Contacts
National Defense Medical College Department of Internal Medicine1